MSSM - Corinne Goldsmith Dickinson Center for MS

New York, New York 10029

0 studies enrolling now · 1 studies all time

What they study most

Relapse-Remitting Multiple Sclerosis

Studies at this site

• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose — Completed